TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 18, 2024 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating...
Daniel Bono Joins Two Six Technologies as SVP of Intelligence Solutions
April 18, 2024 07:30 ET
|
Two Six Technologies
ARLINGTON, Va., April 18, 2024 (GLOBE NEWSWIRE) -- Two Six Technologies (Two Six), a high-growth, technology-focused provider of products and expertise to U.S. national security customers, announced...
Falcon Oil & Gas Ltd - Proposed Fundraising and grant of ORRIs to raise gross proceeds of approximately $8.5 million (£6.8 million)
April 18, 2024 07:30 ET
|
Falcon Oil & Gas Ltd.
THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, BY ANY...
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
April 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and
Investigator-Initiated Pre-Clinical Studies at ESCMID Global (Formerly ECCMID)
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
April 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Global Polylactic Acid Market Size To Worth USD 6.53 Billion By 2033 | CAGR Of 16.40%
April 18, 2024 07:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 18, 2024 (GLOBE NEWSWIRE) -- The Global Polylactic Acid Market Size is to Grow from USD 1.43 Billion in 2023 to USD 6.53 Billion by 2033, at a Compound Annual Growth...
Surgical Sponge Market to Reach $3.7 Billion Globally by 2032 at 5.8% CAGR: Allied Market Research
April 18, 2024 07:30 ET
|
Allied Analytics LLP
Wilmington, New Castle, Delaware, April 18, 2024 (GLOBE NEWSWIRE) -- Allied Market Research has recently published a report, titled, “Surgical Sponge Market Size, Share, Competitive Landscape...
DeFi Technologies Subsidiary Valour Inc. Launches the First Short Spot Bitcoin ETP in the Nordics
April 18, 2024 07:30 ET
|
DeFi Technologies Inc.
The Short Spot Bitcoin ETP (ISIN: CH1149139649) is now trading on the Nordic Growth Market, featuring inverse tracking of Bitcoin's price.
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL DISTRIBUTIONS - Ordinary Shares
April 18, 2024 07:26 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...